September 2021 ZOHU Call
- Antimicrobial Treatment and Prophylaxis of Plague: Recommendations for Naturally Acquired Infections and Bioterrorism Response
- Stronger Together: One Health Coordination During the COVID-19 Pandemic
- CDC Suspension of Dogs Entering the United States from Countries at High Risk for Rabies
Date: Wednesday, September 1, 2021
Time: 2:00-3:00 pm (Eastern Time)
Web-on-Demand: A captioned video recording has been posted.
Course Access Code: onehealth2021
Web-on-Demand: WD2962-090121
Origination Date: October 12, 2021
Expiration Date: October 12, 2023
Presentations:
One Health News from CDC
Colin Basler, DVM, MPH, DACVPM
Deputy Director, One Health Office
Centers for Disease Control and Prevention
wjq3@cdc.gov
Antimicrobial Treatment and Prophylaxis of Plague: Recommendations for Naturally Acquired Infections and Bioterrorism Response
Christina A. Nelson, MD, MPH, FAAP
Medical Officer
Division of Vector-Borne Diseases
Centers for Disease Control and Prevention
wje1@cdc.gov
Stronger Together: One Health Coordination During the COVID-19 Pandemic
Casey Barton Behravesh, MS, DVM, DrPH, DACVPM
Captain, U.S. Public Health Service
Director, One Health Office
Centers for Disease Control and Prevention
dlx9@cdc.gov
CDC Suspension of Dogs Entering the United States from Countries at High Risk for Rabies
Cara E. Williams, DVM, DACVPM
Veterinary Medical Officer
Zoonoses Team
Division of Global Migration and Quarantine
Centers for Disease Control and Prevention
qks2@cdc.gov
Resources
Antimicrobial Treatment and Prophylaxis of Plague: Recommendations for Naturally Acquired Infections and Bioterrorism Response
- Antimicrobial Treatment and Prophylaxis of Plague: Recommendations for Naturally Acquired Infections and Bioterrorism Response | MMWR (cdc.gov)
- CDC website on Plague
- Fact sheet on person-to-person transmission of plague pdf icon[PDF – 2 pages]
- Recommended antimicrobial treatment of plague for clinicians pdf icon[PDF – 3 pages]
- Recommended antimicrobial pre- and postexposure prophylaxis of plague for clinicians pdf icon[PDF – 1 page]
- Plague Bioterrorism CDC website
- Plague Ecology in the United States pdf icon[PDF – 1 page]
Experimental Infection of North American wildlife with SARS-COV-2
- In-depth summary of reports of naturally acquired SARS-CoV-2 infections in domestic animals and farmed or captive wildlifeexternal icon
- Assessing the risks of SARS-CoV-2 in wildlifeexternal icon
Stronger Together: One Health Coordination During the COVID-19 Pandemic
Suspension of Dogs Entering the United States from Countries at High Risk for Rabies
- Federal Register Notice suspension announcement
- List of high-risk countries for dog rabies
- How to apply for a dog import permit (and list of approved POEs)
- What is a valid Rabies Vaccination Certificate
- FAQs for temporary suspension
Overall series objectives:
- Describe 2 key points from the presentation.
- Describe how a multisectoral One Health approach can be applied to the presentation topic.
- Identify an implication for animal and human health.
- Identify a One Health approach strategy for prevention, detection, or response to public health threats.
- Identify 2 new resources from CDC partners.
Disclosures:
In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use, with the exception of Christina Nelson who will be discussing some antibiotics recommended for treatment and prophylaxis of plague that are not FDA approved for this indication (e.g., gentamicin).
CDC, our planners, presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters.
The planning committee reviewed content to ensure there is no bias.
The presentations will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept commercial support for this activity.